# Bristol Myers Squibb

Type: Company

Source: Finance Intelligence Brief — https://getfinancebrief.com/entity/bristol-myers-squibb
Canonical HTML page: https://getfinancebrief.com/entity/bristol-myers-squibb

## Recent coverage (2 stories)

### IHE vs IXJ: 0.39% vs 0.41% Fees — Which Healthcare ETF Wins?
2026-07-19 06:02:54 · Sentiment: Neutral · Impact: 5/10 · Sources: 2

The iShares U.S. Pharmaceuticals ETF (IHE) and iShares Global Healthcare ETF (IXJ) differ in expense ratios (0.39% vs 0.41%), AUM ($1.4B vs $4.1B), and diversification (56 vs 110 holdings). For finance professionals, the 0.02% fee gap may tip the scales for cost-conscious portfolios, but liquidity and global exposure often justify IXJ's slightly higher expense.
Full story: https://getfinancebrief.com/story/ihe-ixj-healthcare-etf-fee-comparison

### 2 Dirt-Cheap Dividend Stocks Yielding 6.5% and 5.8%: PFE and BMY for $1,000
2026-07-08 21:25:08 · Sentiment: Neutral · Impact: 5/10 · Sources: 2

In a market where the S&P 500 yields a paltry 1.4%, Pfizer and Bristol Myers Squibb offer income investors a rare combination of outsized yields and deep value. With forward P/E ratios below 11, these beaten-down pharma giants could re-rate as pipeline successes materialize.
Full story: https://getfinancebrief.com/story/dirt-cheap-dividend-stocks-pfe-bmy-finance

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getfinancebrief.com/guides/methodology for the full editorial methodology.